evenfolio

Chemicals · NSE: SHARDACROP

Sharda Cropchem

Q2 FY27 earnings and concall highlights

Price as of 16 Nov 2026
719.95−1.44%

Q2 FY27 earnings call · Guided by management

Call held 2 Nov 2026 · Read the filing on NSEFiling

10–15​%Revenue growth · FY27Bubna · p. 4
₹550–600​CrRegistration capex · FY27Bubna · p. 4
18–20​%EBITDA margin · FY27Bubna · p. 4
₹419​CrCapex spent in H1 · H1 FY27Mehendale · p. 6
M.Cap
₹6,495Cr
P/E
10.1×
1Y return
−6.80%
From 52W high
−44.5%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue1,052929+13.2%1,074-2.1%
EBITDA164133+23.5%186-11.8%
EBITDA margin15.6%14.3%+130 bps17.3%-172 bps
PBTProfit before tax10786+25.4%118-9.2%
Net profit9274+23.5%88+4.3%
EPS (₹)10.178.24+23.4%9.76+4.2%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue growth · FY2710-15%keptFY27 revenue growth guidance of 10% to 15% maintained
EBITDA margin · FY2718-20%Reason given: better product mix and operating leverage in H2
Capex · FY27Rs 550-600 CrFY27 capex of Rs 550-600 crore planned to increase product registrations

H2 gross margins expected to hold or go up

R. V. Bubna · Chairman and Managing Director · Q&A · p. 11
“Sir, they are expected to hold or go up.”

More figures from the call

Company · Other
946​applicationsProduct registrations in pipeline · 30 September 2026
“That includes Europe, 1,701; NAFTA 333, LATAM 760 and rest of world is 250. And in pipeline, out of 946, Europe is 548, NAFTA is 103, LATAM is 155 and rest of world is 140.”
Shailesh Mehendale · Chief Financial Officerp. 7
Company · Margins and costs
5​yearsAmortisation period · H2 FY27
“this will continue even for balance H2 with this whatever we have already capitalized and spent on intangible assets, on our product registration capex and amortized over a period of 5 years. That is the amortization policy.”
Shailesh Mehendale · Chief Financial Officerp. 11

In short

  1. 01FY27 revenue growth guidance of 10% to 15% maintained.
  2. 02EBITDA margin expected between 18% and 20% for FY27; management said H2 margin can be above 20%.
  3. 03FY27 registration capex planned at Rs 550-600 crore; Rs 419 crore spent in H1, partly on US data compensation.
  4. 04Q2 revenue grew 13% to Rs 1,052 crore; PAT rose 23% to Rs 92 crore; volumes fell 5.1%.
  5. 05Europe softer on heat and drought; management expects it to do well in H2.
  6. 06NAFTA revenue grew about 30%; non-agrochemical business grew 68%, led by conveyor belts.
  7. 07Company is debt-free with Rs 846 crore cash and liquid investments; working capital at 70 days.

Capex

US: US data compensation payments raised H1 capex

Shailesh Mehendale · Chief Financial Officer · p. 6
“we are also focusing on the US, particularly where we have to pay a data compensation and that resulted in this increase in capex in the H1.”

Segments

Europe: Europe expected to do well in the second half as conditions normalise

R. V. Bubna · Chairman and Managing Director · p. 4
“And as conditions normalize, we expect the region to do well in the second half, which is seasonally our stronger period.”

NAFTA: NAFTA revenue grew about 30% in Q2 with better margins

R. V. Bubna · Chairman and Managing Director · p. 3
“NAFTA was the standout of this quarter Revenue from the region grew about 30% year-on-year with significantly better margins.”

LATAM: LATAM agrochemical revenue up over 80% in Q2

R. V. Bubna · Chairman and Managing Director · p. 3
“LATAM also did well with agrochemical revenue up by over 80%.”

Non-agrochemical: Q2 agrochemical revenue up 5% to Rs 840 crore; non-agro up 68% to Rs 212 crore

Shailesh Mehendale · Chief Financial Officer · p. 4
“Coming to the split, agrochemical business grew by 5% year-on-year to INR840 crores, whereas non-agrochemical business grew by 68% year-on-year to INR212 crores.”

Europe: European profitability likely to improve

R. V. Bubna · Chairman and Managing Director · Q&A · p. 7
“So, it is likely to improve. It is likely to improve.”

Demand

Non-agrochemical: Non-agro growth driven mainly by conveyor and rubber belts

R. V. Bubna · Chairman and Managing Director · Q&A · p. 5
“Mainly because of conveyor belts, rubber belts, which are used for transportation of goods and material handling.”

Non-agrochemical: Belt customers ran short of stock and started buying faster

R. V. Bubna · Chairman and Managing Director · p. 6
“People were waiting for the things to improve. And all of a sudden, they found that they are running short of their stocks, and they started buying at a faster speed.”

First-half developments called not normal; expected to normalise in H2

R. V. Bubna · Chairman and Managing Director · p. 8
“Sir, I feel the development that has happened in the first half are not normal. They are going to move towards the normality in the second half.”

Management agreed demand uptick can be seen in H2 and FY28

R. V. Bubna · Chairman and Managing Director · Q&A · p. 9
“Yes, you can see.”

Europe and LATAM: Volume offtake in October described as improving

R. V. Bubna · Chairman and Managing Director · Q&A · p. 9
“It is improving.”

Margins and costs

Q2 price, forex and mix added 18.3%; volume fell 5.1%

R. V. Bubna · Chairman and Managing Director · p. 3
“In terms of revenue analysis for the quarter, the 13% revenue growth was on account of increased prices, positive forex impact and improved product mix of 18.3%. With a volume degrowth of minus 5.1%,”

Product availability in China is good and prices fairly competitive

R. V. Bubna · Chairman and Managing Director · p. 10
“I can tell you that the availability of the products in China is good. The products are available and the prices are fairly competitive.”

Q2 gross margin: Europe 41%, NAFTA about 40%, LATAM 14%, rest of world 31%

35.9​%
R. V. Bubna · Chairman and Managing Director · p. 11
“European region, our gross margins have been 41%, NAFTA region also around 40%, LATAM 14% and rest of the world 31%, overall, 35.9%.”

Generic pricing improving but slower than expected and below pre-COVID

R. V. Bubna · Chairman and Managing Director · p. 12
“It is improving. The speed of improvement is still not as per our expectation, but it is improving. It is still far down compared to the pre-COVID days, but still, it is not impacting the general business so much.”

NAFTA: NAFTA margins helped by good demand and lower availability in H1

R. V. Bubna · Chairman and Managing Director · p. 12
“We have found in first half the demand is good and availability is lesser that is giving us a better possibilities and better margins.”

Debt and working capital

Debt-free with Rs 846 crore cash, bank and liquid investments

Shailesh Mehendale · Chief Financial Officer · p. 5
“The company continues to remain a debt-free company with cash; bank liquid investments stood at INR846 crores as on 30th September 2026.”

Working capital at 70 days, 28 days better than March 2026

Shailesh Mehendale · Chief Financial Officer · p. 5
“Working capital days stood at 70 days as at 30 September '26, showing an improvement by 28 days as compared to March '26.”

Acquisitions and new business

B2C: Company working on B2C sales and reports some results

R. V. Bubna · Chairman and Managing Director · p. 8
“We are also making attempts to have B2C share of the market. We are working on that direction, and we are achieving some good results also.”

Bio chem: Company is adding bio chem products

R. V. Bubna · Chairman and Managing Director · p. 8
“See, we are also going in the bio chem products, and our product are increasing in the bio chem products also.”

One-offs

H1 forex gain Rs 7.1 crore vs Rs 67 crore; PBT Rs 226 crore vs Rs 255 crore

Shailesh Mehendale · Chief Financial Officer · p. 4
“Forex gain stood at INR7.1 crores in H1 FY27 as against forex gain of INR67 crores in H1 FY26. PBT stood at INR226 crores versus INR255 crores last year.”

Q2 forex loss Rs 0.4 crore vs Rs 6.1 crore; Q2 PBT up 25% to Rs 107 crore

Shailesh Mehendale · Chief Financial Officer · p. 4
“Forex loss stood at INR0.4 crores in Q2 FY27 as against loss of INR6.1 crores in Q2 FY26. PBT stood at INR107 crores, an increase of 25% year-on-year.”

Risks

H1 registration spend higher than foreseen due to negotiated data compensation

R. V. Bubna · Chairman and Managing Director · p. 7
“We have not foreseen that we'll have to spend so much on the registrations in the first half. Because some processes were being negotiated, data compensation we had to pay that got negotiated.”

Europe: Heat and drought in Central and Eastern Europe made distributors cautious on restocking

R. V. Bubna · Chairman and Managing Director · p. 4
“The weather challenges were highlighted last quarter continued through the September quarter with extended heat and drought conditions in parts of Central and Eastern Europe. As a result, distributors have taken a cautious approach to restocking.”

Hormuz disruption adds time and freight cost but not affecting performance

R. V. Bubna · Chairman and Managing Director · p. 10
“It is not affecting us much at all because our goods are travelling to western, I mean all around the globe on the western side you know. So it's only taking extra time. The cost of freight is also increasing but it is not affecting the performance.”

Euro-Dollar rate less favourable than before; impact described as limited

R. V. Bubna · Chairman and Managing Director · p. 10
“Earlier, the Euro-Dollar exchange rate was more favourable to us, but the things will get normalized. And another thing is we have no control, but we have not been affected so badly by these exchange rates.”

Tariffs not affecting agrochemical business

R. V. Bubna · Chairman and Managing Director · p. 12
“Tariffs are not affecting agrochemical business at all.”

Other

Q2 revenue up 13% to Rs 1,052 crore; EBITDA up 18% to Rs 164 crore, margin 15.6%

R. V. Bubna · Chairman and Managing Director · p. 3
“Revenue for the quarter grew by 13% year-on-year to INR1,052 crores. Gross margins expanded by around 140 basis points to 35.9%, while EBITDA grew 18% to INR164 crores, taking our EBITDA margin to 15.6%.”

Q2 profit after tax rose 23% to Rs 92 crore

R. V. Bubna · Chairman and Managing Director · p. 3
“Profit after tax for the quarter rose 23% to INR92 crores.”

H1 revenue up 11% to Rs 2,125 crore

Shailesh Mehendale · Chief Financial Officer · p. 4
“Coming to the H1 FY27 performance, revenue stood at INR2,125 crores in H1 FY27 versus INR1,914 crores in H1 FY26, an increase of 11% year-on-year.”

H1 EBITDA up 22% to Rs 343 crore; margin 16.1%

Shailesh Mehendale · Chief Financial Officer · p. 4
“EBITDA grew by 22% to INR343 crores with EBITDA margin at 16.1% as against 14.7% in H1 FY26, an increase of 140 basis points.”

ROCE at 25.9% and ROE at 20.1%

Shailesh Mehendale · Chief Financial Officer · p. 5
“ROCE stood at 25.9% and ROE stood at 20.1%, reflecting the continued efficiency of our asset-light registration-led business model.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools